GB774882A - Improvements in or relating to phenthiazine derivatives - Google Patents

Improvements in or relating to phenthiazine derivatives

Info

Publication number
GB774882A
GB774882A GB18213/54A GB1821354A GB774882A GB 774882 A GB774882 A GB 774882A GB 18213/54 A GB18213/54 A GB 18213/54A GB 1821354 A GB1821354 A GB 1821354A GB 774882 A GB774882 A GB 774882A
Authority
GB
United Kingdom
Prior art keywords
phenthiazine
methyl
methylphenthiazine
piperidyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB18213/54A
Inventor
Robert Michel Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc SA
Original Assignee
Rhone Poulenc SA
Societe des Usines Chimiques Rhone Poulenc SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc SA, Societe des Usines Chimiques Rhone Poulenc SA filed Critical Rhone Poulenc SA
Publication of GB774882A publication Critical patent/GB774882A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the preparation of compounds of the formula: <FORM:0774882/IV(b)/1> and their salts including quaternary ammonium compounds wherein the -CH2- bridge is directly connected to a ring carbon atom of the piperidine nucleus, preferably in the 3- or 4-position, at least one of the benzene rings of the phenthiazine nucleus may contain a halogen, alkyl, alkoxy, phenyl or phenoxy substituent group, preferably in the 3-position and R represents a hydrogen atom or an alkyl group containing not more than 4 carbon atoms or a benzyl group, comprises reducing a phenthiazine compound of the general formula: <FORM:0774882/IV(b)/2> (wherein Hal represents a halogen atom and the phenthiazine nucleus may be substituted as aforesaid) by the application of known methods for the reduction of pyridine derivatives to the corresponding piperidine derivatives. The reduction may be effected catalytically, suitably with an Adams platinum catalyst in absolute ethanol (at ordinary or increased temperature and pressure) or in aqueous alcohol (at increased temperature and pressure). Substituents on the piperidine nitrogen atom may be present in the starting material or be introduced by alkylation processes. In Example (1): 1-methyl-3-(101-phenthiazinylmethyl)-pyridinium iodide is hydrogenated in absolute ethanol in presence of Adams platinum catalyst to give 1-methyl-3-(101-phenthiazinylmethyl)-piperidine hydriodide from which the free base, hydrochloride and picrate are prepared. Similarly obtained are 3-methyl - 10 - (1 - methyl - 3 - piperidyl) - methylphenthiazine; (3) 3 - chloro - 10 - (1 - methyl-3 - piperidyl) methylphenthiazine; (4) 3-methoxy - 10 - (1 - methyl - 3 - piperidyl) methylphenthiazine; (5) 10 - (1 - benzyl - 3 - piperidyl) methylphenthiazine; (6) 3 - chloro-10 - (1 - methyl - 4 - piperidyl) - methylphenthiazine; (7) 10 - (1 - methyl - 4 - piperidyl) methylphenthiazine. In Example (8): 10-(31-pyrdylmethyl)-phenthiazine hydrochloride is hydrogenated in an autoclave at 60-90 kg/cm.2 pressure and 60 DEG C. to give 10-(31-piperidylmethyl)-phenthiazine which is recovered as the methanesulphonate. Starting materials of the second formula above are obtained by the action of a halogenomethylpyridine, preferably in the presence of a condensing agent, on the appropriate phenthiazine and reaction of the product with a compound R Hal. In this manner are prepared 10 - (31 - pyridylmethyl) - phenthiazine and corresponding compounds having 3-methyl, chloro and methoxy substituents, 3-chloro-10-41 - pyridylmethyl) - phenthiazine and 10-(41-pyridylmethyl) - phenthiazine and quaternary compounds of these bases, for use in the above examples. Specification 774,883 is referred to.
GB18213/54A 1954-06-21 1954-06-21 Improvements in or relating to phenthiazine derivatives Expired GB774882A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB333362X 1954-06-21
GB160655X 1955-06-16

Publications (1)

Publication Number Publication Date
GB774882A true GB774882A (en) 1957-05-15

Family

ID=26251762

Family Applications (2)

Application Number Title Priority Date Filing Date
GB18213/54A Expired GB774882A (en) 1954-06-21 1954-06-21 Improvements in or relating to phenthiazine derivatives
GB17971/55A Expired GB774883A (en) 1954-06-21 1954-06-21 Phenthiazine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB17971/55A Expired GB774883A (en) 1954-06-21 1954-06-21 Phenthiazine derivatives

Country Status (4)

Country Link
CH (1) CH333362A (en)
DE (1) DE1052403B (en)
FR (1) FR1171946A (en)
GB (2) GB774882A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945855A (en) * 1958-10-21 1960-07-19 Mead Johnson & Co 10-(1-substituted-3-pyrrolidylmethyl) phenothiazines
DE1092476B (en) * 1958-04-24 1960-11-10 Rhone Poulenc Sa Process for the preparation of phenthiazine derivatives
DE1100635B (en) * 1958-04-22 1961-03-02 Rhone Poulenc Sa Process for the preparation of phenthiazine derivatives
EP0404359A1 (en) * 1989-05-27 1990-12-27 Pfizer Limited Dibenzothiazepine derivatives useful as antispasmodic agents
JP2014521678A (en) * 2011-08-02 2014-08-28 ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー Selective inhibition of MALT1 protease by phenothiazine derivatives
WO2022187568A1 (en) * 2021-03-05 2022-09-09 Monopteros Therapeutics, Inc. (s)-mepazine salt forms, process of preparing, and formulations thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1100635B (en) * 1958-04-22 1961-03-02 Rhone Poulenc Sa Process for the preparation of phenthiazine derivatives
DE1092476B (en) * 1958-04-24 1960-11-10 Rhone Poulenc Sa Process for the preparation of phenthiazine derivatives
US2945855A (en) * 1958-10-21 1960-07-19 Mead Johnson & Co 10-(1-substituted-3-pyrrolidylmethyl) phenothiazines
EP0404359A1 (en) * 1989-05-27 1990-12-27 Pfizer Limited Dibenzothiazepine derivatives useful as antispasmodic agents
US5071844A (en) * 1989-05-27 1991-12-10 Pfizer Inc. 5,11-dihydrodibenzo[b,e][1,4]-thiazepines useful as gastro intestinal selective calcium antagonists
JP2014521678A (en) * 2011-08-02 2014-08-28 ヘルムホルツ ツェントラム ミュンヘン ドイチェス フォーシュングスツェントラム フュール ゲズントハイト ウント ウンヴェルト ゲーエムベーハー Selective inhibition of MALT1 protease by phenothiazine derivatives
US9504692B2 (en) 2011-08-02 2016-11-29 Helmholtz Zentrum Munchen, Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Selective inhibition of MALT1 protease by phenothiazine derivatives
WO2022187568A1 (en) * 2021-03-05 2022-09-09 Monopteros Therapeutics, Inc. (s)-mepazine salt forms, process of preparing, and formulations thereof

Also Published As

Publication number Publication date
GB774883A (en) 1957-05-15
CH333362A (en) 1958-10-15
DE1052403B (en) 1959-03-12
FR1171946A (en) 1959-02-03

Similar Documents

Publication Publication Date Title
Turner et al. Studies on imidazole compounds. I. 4-Methylimidazole and related compounds
GB952187A (en) Thermographic copying materials
KR830007644A (en) Process for preparing carbostyryl compound
Adamson et al. 212. Aminoalkyl tertiary carbinols and derived products. Part III. 3-Tertiary-amino-1-aryl-1-(2-pyridyl)-propan-1-ols and-prop-1-enes
GB774882A (en) Improvements in or relating to phenthiazine derivatives
US2695290A (en) Derivatives of indole and method for the production thereof
US3309370A (en) Bicycloalkyl piperazine derivatives and process
Biel Antihistaminics. I. Some Ethylene Diamines and an Aminoether
GB744773A (en) Indole derivatives
US2942003A (en) Process for preparing naphtho [1, 2-d]-thiazoles
GB822592A (en) Carbazole derivatives and process for the production thereof
Kaye 2-Lepidyl substituted diamines
US3105836A (en) Certain 3-(pyridyl lower alkyl)-2-(tertamino-lower alkyl)-indene quaternary salts
Corse et al. 2-Methoxy-6-chloro-9-(N-substituted-amino)-acridines. II. Compounds Derived from Cyclic Secondary Amines1
GB819886A (en) New phenthiazine derivatives and processes for their preparation
US4590192A (en) Benzisothiazoles, their pharmaceutical compositions, and method of use
KING et al. Reactions of Pyridine-Type Bases with Iodine and Certain Quinolines or Isoquinolines Containing a Reactive Methyl Group
Kostic‐Rajacic et al. Mixed Dopaminergic/Serotonergic Properties of Several 2‐Substituted 4‐[2‐(5‐Benzimidazole) ethyl]‐1‐arylpiperazines
SU414790A3 (en) METHOD OF OBTAINING 2,3-DIHYDRO-5H-IMIDAZO [2,1-o] IZOINDOL DERIVATIVES12
US3074954A (en) Heterocyclic compounds
GB715236A (en) Improvements relating to new 1-substituted-4-aminopiperazine derivatives and the preparation thereof
GB783627A (en) Improvements in or relating to methods of preparing chemical compounds containing the pyrrocoline nucleus and new chemical compounds produced thereby
Begtrup 4-(1, 2, 3-triazolio) sulfides, a new mesoionic system
Burger et al. Iodinated Dialkylaminoalkyl Pyridyl Ethers
US3880850A (en) Pyrimido(4,5-d)pyridazine derivatives and process for producing them